Structure-function relationship of heart valves in health and disease by Sotiris Korossis (5214488)
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
116,000 120M
TOP 1%154
4,000
Chapter 1
Structure-Function Relationship of Heart Valves in
Health and Disease
Sotirios Korossis
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.78280
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
tiri   r i
dditional infor ation is available at the end of the chapter
Abstract
The heart valves allow unidirectional and unobstructed passage of blood without 
regurgitation, trauma to blood elements, thromboembolism, and excessive stress con-
centrations in the leaflet and supporting tissue. In order to achieve this, the heart valves 
rely of their unique macroscale anatomy, histoarchitecture and ultrastructural features 
that allow them to accommodate repetitive changes in shape and dimension through-
out the cardiac cycle. This chapter is focused on the structure-function relationship of 
the heart valves, with particular focus on the aortic and mitral valves, discussing how 
the biochemical, histoarchitectural and anatomical features influence valvular function 
during the cardiac cycle and how valvular function dictates valvular architecture and 
ECM constitution. The chapter examines the structure-function relationship of valvular 
tissue by correlating its microscale histoarchitecture and biochemical constitution to its 
mesoscale biomechanics and macroscale function during the cardiac cycle. Moreover, the 
chapter examines the influence of pathological alterations on the histoarchitectural and 
biochemical characteristics of the valves on their biomechanical behavior.
Keywords: heart valves, histoarchitecture, biochemistry, biomechanics, 
structure-function
1. Introduction
Connective tissues comprise a network of interweaving fibers with polysaccharide ground 
substance immersed in a pool of ionic fluid. Cells are attached to the fibers and are responsible 
for replenishing the extracellular matrix (ECM) macromolecules and the ground substance 
that carry out the physical function. The ECM contains three major classes of macromolecules, 
including structural proteins, such as collagen, elastin and fibrillin, specialized proteins, such 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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as fibronectin and laminin, and glycosaminoglycans (GAGs) and proteoglycans. The ECM is 
involved in many normal and pathologic processes, playing an important role in tissue devel-
opment and pathology, and mechanotransduction of the cells [1]. The ground substance is a 
hydrophilic gel that fills the spaces between the cells and the ECM. Dense connective tissues 
contain a small amount of ground substance and the cells are mostly fibroblasts. Loose con-
nective tissues contain significantly more ground substance. Ground substance in normal con-
nective tissues is clear and colorless and its composition varies with the tissue. It has a dense 
consistency similar to that of maple syrup, due to the presence of GAGs and proteoglycans.
The structure and hence the properties of a tissue are dependent on the chemical and physical 
nature of its constituents and their relative amounts. For example, nervous tissue consists almost 
entirely of cells, whereas bone is composed of collagen fibers and calcium phosphate minerals 
with minute quantities of cells and ground substance. Depending on the functional requirements 
on a particular tissue, the organization of its ECM macromolecules, cells and ground substance, 
as well as its resulting mechanical properties, vary. The simplest structure from the point of view 
of the collagen fibers consists of parallel fibers, as in tendons and ligaments. The 2D and 3D net-
works of the skin are more complex, whereas the structure of blood vessels and heart valves are 
the most complex ones. This chapter describes the basic biochemistry and function of the major 
structural proteins, collagen and elastic fibers, as well as the major GAGs and proteoglycans, 
present in the ECM of the heart valves, and illustrates their physiological and pathological sig-
nificance. In addition it examines the structural basis, organization and structure-function rela-
tionship of valvular tissue, with particular focus on the aortic and mitral valves, by correlating its 
microscale histoarchitecture and biochemical constitution to its mesoscale biomechanics. Finally, 
the chapter examines the influence of pathological alterations, as a result of major valvular dis-
ease, on the histoarchitectural, constitutional and biomechanical characteristics of the valves.
2. Structure-function of major ECM proteins of valvular tissue
Proteins are the most abundant organic components of the human body. There are roughly 
100,000 different kinds of proteins and they account for about 20% of the total body weight [2]. 
All proteins contain carbon, hydrogen, oxygen, and nitrogen and in some cases small quanti-
ties of sulfur. Proteins are classified according to the function they perform into structural, 
contractile and transport proteins, buffers, enzymes, antibodies and hormones. From these 
types, structural proteins such as collagen, elastin and keratin create a 3D framework for the 
body, providing strength, organization, and support for cells, tissues, and organs. Proteins 
consist of chains of amino acids, with each amino acid comprising a central carbon atom to 
which four groups are attached, including a hydrogen atom, an amino group (–NH2), a carbox-ylic acid group (–COOH) and a variable group, known as an R-group or side chain (Figure 1a). 
The amino and carboxylic acid groups are hydrophilic groups, and amino acids are relatively 
small, soluble molecules. Depending on the side chain the molecular structure changes dras-
tically, giving each amino acid its individual chemical properties. The simplest R-group is 
hydrogen, which forms glycine (Gly). Within the physiological pH range, the carboxylic acid 
groups on many amino acids give up their hydrogen, going from –COOH to –COO− and 
getting negatively charged. Two amino acids can be linked by dehydration, which creates 
a covalent bond between the carboxylic acid group of one amino acid and the amino group 
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of the other (Figure 1b). Such a bond is known as a peptide bond, and the molecule created 
dipeptide. The chain can be lengthened by the addition of more amino acids forming polypep-
tides. Polypeptides containing more than 100 amino acids are usually called proteins. Proteins 
contain negatively charged amino acids and, therefore, have a net negative charge [2, 3].
Proteins are very versatile and have a variety of different functional properties, which are 
determined not only by the R-groups on their constituent amino acids, but also by their shape. 
The primary determinant of shape is the sequence of amino acids (primary structure). The 20 
major amino acids present in the human body, can be linked in a high number of combinations, 
creating proteins that vary in shape and function. Changing the identity of a single amino acid 
out of 10,000 or more in a protein may significantly alter its functional properties. Further 
levels of structural complexity include the secondary, tertiary, and quaternary structures. The 
secondary structure appears as parts of the polypeptide chain, which are bonded together 
by hydrogen bonding. This usually creates a simple spiral, known as α-helix, or less often a 
flat pleated sheet, or both. The tertiary structure results primarily from interactions between 
the polypeptide chain and the surrounding water molecules, and partly from interactions 
between the R-groups of amino acids in different parts of the molecule. Structural proteins 
contain several polypeptide chains; each one with its own secondary and tertiary structure. 
Interactions between these chains determine the quaternary structure of these proteins. The 
Figure 1. (a) Amino acid structure. (b) Peptide bond formation. (c) Schematic of the collagen triple helix (□ glycine; ♦ 
other amino acids). (d) Triple helices of procollagen I, II and III; Gal: galactose residue; Glu: glucose residue; redrawn 
from Nimni (1988) [5].
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tertiary and quaternary structure of complex proteins depends not only on their amino acid 
sequence, but also on the local environmental characteristics, with small changes in the ionic 
composition, temperature, or pH affecting protein function [1–3].
2.1. Collagen fibers
Collagen is the major insoluble fibrous protein and the basic structural element for soft and 
hard tissues, supporting elements in the ECM. It is the main load-carrying element giving 
mechanical integrity and it is present in a variety of structural forms in different tissues. 
Collagen contains large domains of helical conformation, created by three α-helix polypeptide 
chains, each containing 1050 amino acids. The individual α-helix chains are left-handed helices 
with approximately three amino acid residues per turn. The chains are, in turn, coiled together 
to give a right-handed coiled triple helix (Figure 1c), which is the molecular basis of tropocol-
lagen, the precursor of collagen. All collagens have been shown to contain three α-helix chains 
of similar structure, with each collagen type differentiating its individual properties mainly 
by incorporating segments that do not follow the triple helix conformation, and fold the col-
lagen molecule into different kinds of three-dimensional structures [3]. The collagen molecule 
contains a high amount of three amino acids, including Gly, proline (Pro) and hydroxyproline 
(HYP), and since the latter is unique in collagen (elastin contains minute amount), the col-
lagen content in a tissue can be easily determined by a HYP assay. The characteristic repeating 
amino acid sequence of the collagen molecule is Gly-X-Y, where X and Y can be any amino acid 
but are often proline and HYP and less often lysine (Lys) and hydroxylysine (Hyl) [4]. In the 
amino acid sequence of the collagen molecule every third residue is Gly (Figure 1c), whereas 
proline and HYP follow each other relatively frequently [3, 5, 6]. Hydrogen bonding between 
the peptide bond NH of Gly and the peptide carbonyl (C=O) group in an adjacent polypeptide 
(Figure 1b), holds the three α-helix peptide chains together in a three-stranded helix, which 
is formed due to the fixed angle of the C-N peptidyl-Pro or peptidyl-HYP bond [3]. In addi-
tion, the α-helixes are cross-linked via Lys, whereas collagen III also contains cysteine (Cys) 
that can be cross-linked within molecules through disulfide bonds [7]. The side chains of the 
amino acids of the collagen molecule are highly non-polar and, hence, hydrophobic, seeking 
the greatest number of contacts with the non-polar side chains of other amino acids. In cases 
that the hydrophobic contact is destroyed by a solution such as urea, ultrastructural changes 
are generated in the collagen fibers, such as shrinking [7, 8]. Collagen stability is also affected 
by the water content in its intra- and inter-chain structure. Specifically, when the water content 
is decreased the collagen structure gets destabilized, whereas lyophilized collagen also dem-
onstrates decreased solubility [7, 8].
Depending on the source of tissues the collagen chains are different. A characteristic example 
is demonstrated in Figure 1d, which shows the triple helix conformation of three types of colla-
gen, differing in α-helix composition and degree of glycosylation. The amino acid compositions 
of these chains are listed in Table 1. The collagen α-helix chains are synthesized by ribosomes 
attached to the rough endoplasmic reticulum (ER) as longer precursors called pro-α-helix chains. 
Subsequently, the pro-α-helix chains undergo a series of covalent modifications in the ER and 
fold into triple-helical procollagen molecules (Figure 1d) before they are released from the cells. 
Specifically, short non-triple-helical segments at either end (C– and N–terminus) of the pro-α-helix 
chains, called propeptides and containing Hyl, are covalently linked by disulfide bonds to form 
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trimers and align the three α-helix chains prior to the triple helix formation in the ER. In addition, 
specific Pro and Lys residues in the middle of the chains are hydroxylated by hydroxylases, and 
asparagine-linked oligosaccharides are added to the C-terminal propeptide, whereas galactose 
(Gal) or galactose-glucose (Gal-Glu) residues are attached to Hyl residues, in a process known as 
glycosylation [4]. Glycosylation is a common form of post-translational modification of proteins 
that occurs during processing in the ER and provides intrinsic stabilization of the protein struc-
ture and, thus, increases protein half-life and protects them against denaturation or proteolytic 
degradation [9–11]. The modifications of the α-helices in the ER facilitate their zipping from C- to 
N-terminus to form stable triple helices in the procollagen molecule. These modifications also 
allow the binding of the chaperone protein Hsp47 to the procollagen, which has been suggested 
to further stabilize the helices and/or prevent premature aggregation of the trimers [4]. The modi-
fication of the procollagen in the ER is crucial for the subsequent formation of mature collagen, 
Table 1. Amino acid residues per 1000 total residues in human collagen [6, 20] and elastin [7].
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whereas defects in this process have been reported to have serious consequences. For example, 
hydroxylation requires the facilitation of vitamin C, and cells deprived of it cannot hydroxylate 
the procollagen chains sufficiently to form stable triple helices. As a result, non-hydroxylated 
procollagen chains are degraded within the cell and no collagen fibers can be formed [12]. As a 
result, in tissues where the turnover (degradation and replacement) of the collagen occurs rela-
tively rapidly, such as in blood vessels and heart valves that experience significant collagen fiber 
damage due to the repetitive deformation during normal function, the gradual loss of preexisting 
ECM collagen, which is not supplemented by newly-formed collagen, leads to tissues that are 
extremely fragile and prone to disintegration [13]. However, in other tissues, such as bone, the 
turnover of collagen is very low, with collagen molecules reportedly remaining intact for about 
10 years [13]. Following the post-translational modification in the ER, the procollagen molecules 
are transported to the Golgi apparatus, where they are associated laterally to form small bundles, 
before they are secreted in the extracellular space (exocytosis). Following exocytosis, procollagen 
peptidases cleave the N-terminal and C-terminal propeptides, transforming the procollagen to 
tropocollagen molecules, approximately 300 nm long and 1.5 nm in diameter [14]. This allows 
the tropocollagen molecules to assemble into collagen fibrils by covalent cross-linking between 
two Lys or Hyl residues at the C-terminus of one tropocollagen molecule with two similar resi-
dues at the N-terminus of an adjacent molecule. These cross-links stabilize the packing of the 
tropocollagen molecules in a quarter-staggered array architecture (Figure 2a), generating strong 
fibrils with a diameter of 50–200 nm and several micrometers long, depending of the species 
and tissue, with a cross-striated appearance under transmission electron microscopy (Figure 2b) 
[3–6]. The striation has a period (D) of approximately 67 nm, with the lighter part of the stria-
tion representing a gap of approximately 0.6D between successive molecules (Figure 2b) [6, 15]. 
The covalent cross-linking between Lys and Hyl residues of adjacent collagen molecules confers 
significant strength to the collagen fibrils. This type of covalent bonding is only found in collagen 
and elastin, and its inhibition results in a dramatic reduction of the tensile strength of the fibrils, 
making tissues fragile and prone to tearing. The extent and type of cross-linking vary from tissue 
to tissue; in tissues where tensile strength is crucial, collagen is highly cross-linked [13]. Although 
the alignment of the tropocollagen molecules in the collagen fibril has been idealized as perfectly 
straight and parallel in Figure 2a, in reality they are bent in various degrees, depending on the 
attachment of water molecules, and have varying spacing between neighboring molecules [6]. 
Bundles of collagen fibrils form collagen fibers, with diameters ranging between 0.2 and 12 μm, 
and increasing with age, whereas their length depends on the tissue [16, 17]. Moreover, collagen 
fibers appear to be crimped (Figure 2c), and when the tissue is stretched the amplitude of the 
crimp decreases [6, 18, 19]. It has been suggested that the crimping of the collagen fibers is gener-
ated by the shrinking of the non-collagenous components of the ground substance, which causes 
collagen fiber buckling [19], whereas enzymatic digestion of the non-collagenous components of 
the ground substance alters the mechanical properties of the tissue [6].
Collagens are differentiated in terms of their ability to form fibers and organize the fibers 
into networks. There are at least 20 types of collagen that have been identified and participate 
in the formation of the ECM of tissues [4]. Among these, types I, II, II, V and XI are fibrillar 
collagens, with types I, II, III comprising 80–90% of the total collagen in the body [3]. Collagen 
I is present in almost any tissue, but it predominantly present in bone, dermis, placental mem-
branes, tendons, ligaments, blood vessels and heart valves. Collagen II is mainly located in 
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hyaline cartilage and cartilage-like tissues and the vitreous body of the eye [20]. Similarly 
to collagen I, collagen III is also quite common in most tissues and represents a major con-
stituent of blood vessels and heart valves, as well as other more distensible connective tissue. 
Collagen V has a similar distribution to collagen I, but it is a minor constituent in the tissues, 
whereas collagen XI is found mainly in cartilage and is distributed similarly to collagen II [21]. 
Collagen VI and IX represent a separate class of collagens that are associated to fibrillar colla-
gens, linking them to each other or to other ECM components. The collagen VI tropocollagen 
comprises short triple-helical regions of approximately 60 nm long, separated by globular 
regions of approximately 40 nm long [3]. Collagen VI is common in placental villi [6] and has 
also been found in many other connective tissues, where it is bound to collagen I fibrils and 
has been suggested to enable the formation of thicker collagen I fibers [3]. Collagen IX is a pro-
teoglycan in that one of its polypeptide subunits serves as the core protein for a chondroitin 
Figure 2. (a) Quarter-staggering of tropocollagen I molecules in collagen fibrils; redrawn from Lodish et al. (2003) [4]. (b) 
Transmission electron microscopy of the decellularised mitral valve leaflet showing the striations in the collagen I fibrils; 
adopted with permission from Granados et al. (2017) [68]. (c) Histological section of the anterior mitral valve leaflet 
stained with sirius red under polarized light, showing the crimping in the collagen I fibers; adopted with permission 
from Roberts et al. (2016) [18]. (d) Immunofluorescence staining for collagen IV produced by human endothelial cells 
seeded on culture plastic (yellow/orange: anti-collagen-IV; blue: Hoechst stain for nuclei); adopted with permission 
from Pflaum et al. (2017) [132]. (e) Two photon microscopy of the atrial surface of the native anterior mitral valve leaflet, 
showing the elastin in the elastic fiber network.
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sulfate side chain [6]. The collagen IX molecule comprises two long triple helices connected 
by a flexible link, on the α2(IX) chain of which the chondroitin sulfate glycosaminoglycan 
(GAG) chain is covalently linked to [3, 6]. Collagen IX does not assemble into fibrils, due to 
its interrupted triple-helical conformation. Nevertheless, it is bound along collagen II fibrils at 
regular intervals, binding them to the GAG- and proteoglycan-rich ECM, and also reportedly 
contributing to their assembly in collagen II fibers [22]. In addition to collagen IX, collagens 
XVIII and XV also function as core proteins in proteoglycans.
Collagen IV is a sheet-forming collagen, which is of particular importance for endothelial-
ized and epithelialized tissues, since, together with laminin, is the primary component of all 
basal laminae, forming their basic two-dimensional fibrous network. Collagen IV, as well as 
most of the other ECM components that form the basal laminae, is synthesized by the cells 
that reside on it (Figure 2d) [4]. The collagen IV molecule is formed by a 400-nm-long triple 
helix with large globular domains at the C-terminus and smaller non-collagen ones at the 
N-terminus, whereas Gly-X-Y sequences of its α-helices are interrupted with segments that 
do not form a triple helix, and introduce flexible links and flexibility into the molecule [3, 4]. 
Following exocytosis into the extracellular space, adjacent collagen IV molecules assemble 
either into groups of 4 molecules by association of their globular N-terminus domains, yield-
ing tetrameric units, or into pairs by association of their globular C-terminus domains, yield-
ing dimeric units [4]. Subsequently, triple-helical regions from several tetrameric and dimeric 
units associate laterally, similarly to the case of fibril formation in fibrillar collagens, to form 
branching two-dimensional mesh-like fibrous networks to which other ECM components and 
adhesion receptors can bind (Figure 2d). In addition to the aforementioned types of collagen, 
other minor classes of collagens include anchoring collagens, such as collagen VII, which con-
nects the basal lamina to the underlying connective tissue, transmembrane collagens, which 
function as cell adhesion receptors, and host defense collagens, which help the body to recog-
nize and eliminate pathogens [4].
Collagen is encoded by approximately 30 genes, whereas its biosynthetic pathway involves a 
number of post-translational phases. Owning to this, collagen-related disease most commonly 
arise from genetic mutations affecting collagen encoding or post-translational modifications, 
whereas nutritional deficiencies might also affect the post-translational modifications, assem-
bly, or secretion of collagen [1, 13]. Moreover, autoimmune conditions have also been reported 
to affect collagen fibers, whereas a number of different bacteria and viruses can degrade 
collagen or interfere with its production pathway [1]. Goodpasture’s autoimmune disease 
causes self-attacking antibodies to bind to the α-helices of collagen IV, setting off an immune 
response that causes cellular damage [4]. The Ehlers-Danlos syndrome comprises at least 10 
types of congenital disorders whose principal features include tissue hyper-extensibility and 
abnormal fragility. Type IV disorder is the most serious one, especially for the cardiovascular 
system, which affects collagen III and is associated with spontaneous rupture of arteries or 
the bowel [1, 13]. Type VI disorder, together with the Bruck syndrome and Menkes disease, 
are associated with lysyl hydroxylase deficiency, leading to defective cross-linking of collagen 
and elastin [1, 4, 23], whereas type VIIC disorder causes formation of abnormally thin and 
irregular collagen fibrils [1]. Moreover, the Alport syndrome is another genetic disorder that 
alters the C-terminal domain of the tropocollagen IV α-helices and affects the structure of 
collagen IV fibers, causing structural abnormalities in basal laminae [1, 4].
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2.2. Elastic fibers
Elastin is an another structural insoluble fibrous protein, forming a large proportion of the ECM 
of arteries and veins, especially near the heart, and in other deformable tissues such as ligaments, 
heart valves, skin, lungs and areolar connective tissue. Elastin is the dominant ECM protein in 
arteries, contributing about 28–50% of the dry weight of the aorta [13, 23, 24], whereas in elastic 
ligaments and tendons the elastin content attributes 50 and 4% of the dry weight, respectively 
[23]. Elastin is the main component of the elastic fibers, which are major insoluble assemblies 
of the ECM that generate resilience into the tissues by providing a mechanism that permits 
tissues to deform under load and passively recoil to their original configuration after the load 
is released, preventing dynamic tissue creep [13, 24–26]. These properties are critical to the 
function of heart valves, which undergo repeated dynamic cycles of large extension and recoil 
during opening and closing. In addition to contributing to ECM resilience, the elastic fibers are 
also an important load-bearing structure, complementing the function of the collagen fibers at 
the sites where mechanical energy needs to be stored [25]. In particular, the elastic fibers dictate 
tissue mechanics at low strains before the stiffer collagen fibers are engaged at higher strains 
[24]. Elastic fibers are the most linearly elastic biosolids known, and are at least five times more 
extensible than rubber. They are generally twisted or straight with a diameter ranging between 
about 0.2 and 1.5 μm forming coarse networks (Figure 2e) [27]. In dense elastic tissues, such 
as the arteries, the elastic fibers fuse during development to form flattened co-centric sheets, or 
elastic laminae, with numerous fenestrations [17, 28, 29].
The elastic fibers are complex structures that comprise several components, with elastin and 
microfibrils constituting their two major ones [30]. Ultrastructurally, elastic fibers are composed 
of a homogeneous inner core of laterally packed, thin cross-linked elastin filaments that make up 
more than 90% of fibers, and an outer fibrillar mantle that consists of microfibrils and surrounds 
the elastin, accounting for 5–10% of the elastic fibers [23, 25, 26]. The amino acid compositions of 
these components are given in Table 1 [7]. The microfibrils are organized into 8–16 nm beaded 
fibrils and are predominantly made of five distinct proteins, including two fibrillin glycoproteins 
(fibrillin-1 and fibrillin-2) and two microfibril-associated glycoproteins (MAGP-1 and MAGP-2) 
[13, 23, 31]. Additional components of the elastic fibers include lysyl oxidase, elastin-binding 
protein (EBP), proteoglycans, osteopontin, emilin, fibulin-1, and various microfibril-associated 
proteins [23]. Early development of the elastic fibers involves the assembly of fibrillin molecules 
in the extracellular space, in enfoldings of the cell surface, into head-to-tail microfibrillar arrays 
of approximately 160 nm in length that are cross-linked by transglutaminase to form mature 
beaded microfibrils. Transglutaminase forms γ-glutamyl-e-Lys isopeptide bonds within or 
between peptide chains [25, 29]. The mature microfibrils, which have a length of approximately 
100 nm, form loosely-packed parallel bundles with an one-third-staggered architecture, that 
have been hypothesized to be stabilized by inter-microfibrillar crosslinking [25]. Non-stretched 
microfibrils have been reported to have a beaded periodicity of approximately 56 nm, whereas 
models have predicted up to 8 fibrillin molecules in the microfibril cross-section [25, 27, 31, 32].
Following the formation of the microfibril bundles, intracellularly-produced tropoelastin [33] is 
gradually deposited among the preformed template of fibrillin-rich microfibrils, until the elas-
tic fibers reach full maturation [7, 23, 25, 26]. Some tissues, even at their mature state, contain 
bundles of microfibrils devoid of tropoelastin (oxytalan fibers), as well as sites where bundles 
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of microfibrils are only partially intermixed with tropoelastin (elaunin fibers), and never devel-
oped into fully mature elastic fibers [26]. These microfibril states represent interruptions in suc-
cessive phases of elastic fiber development, indicating that microfibrils can be both progenitors 
of fully mature elastic fibers in fetal tissues, and independent connective tissue components 
(oxytalan fibers) [26, 34]. Tropoelastin is the soluble precursor of elastin, which is synthesized 
by fibroblasts and smooth muscle cells (SMCs) and secreted as a soluble and highly hydropho-
bic monomer of about 750 amino acids long [13, 24, 35]. Similarly to tropocollagen, tropoelastin 
contains an abundance of Pro and Gly, but is not glycosylated and contains minute amounts of 
HYP and no Hyl [13]. Human tropoelastin contains more than 30% Gly, whereas about 75% of 
its amino acid sequence is made up of just four hydrophobic amino acids, including Gly, valine 
(Val), alanine (Ala) and Pro [23]. Structurally, tropoelastin comprises two types of alternating 
segments, including hydrophobic segments and Ala-/Lys-rich α-helical segments, which form 
cross-links between adjacent molecules [13]. During tropoelastin deposition among the micro-
fibrils, the latter get displaced to the periphery of the growing fiber, allowing the formation 
of the elastin core by the accumulation of tropoelastin molecules [13, 31]. The accumulated 
tropoelastin molecules couple covalently to each other by lysyl oxidase-derived cross-links, to 
form the polymeric elastin, stabilizing the elastin core of the elastic fibers [25, 31]. Lysyl oxidase 
catalyzes the selective oxidative deamination of Lys residues in tropoelastin, leading to the 
formation of bi-functional (dehydrolysinonorleucine and allysine aldol), tri-functional (dehy-
dromerodesmosine) and tetra-functional (desmosine and isodesmosine) crosslinks [25]. The 
resulting cross-linked mature elastin is a very stable and persistent structure that is extremely 
hydrophobic and insoluble due to the extensive cross-linking at Lys residues [23]. The high 
stability of elastin has been attributed to the low content of polar amino acid residues, including 
the anionic Lys, histidine (His) and arginine (Arg), as well as the cationic aspartic acid (Asp) 
and glutamic acid (Glu) [7].
The elastic recoil generated by the elastic fibers is a critical attribute for tissues that are required 
to undergo repetitive stretch/relaxation cycles. Tropoelastin is among the most elastic pro-
teins, with a capacity to stretch eight times its resting molecular length (≈20 nm) and recoil 
without damage, while showing no hysteresis after repeated stretch and relaxation cycles, 
demonstrating a near perfect spring behavior with minimal energy loss [36, 37]. Atomic force 
microscopy studies have estimated the Young’s modulus of tropoelastin to approximately 
3 kPa [37], which is two order of magnitudes smaller (more flexible) than mature cross-linked 
elastin, estimated between 0.6 and 1.1 MPa [6, 35], four orders of magnitude smaller than 
microfibrils, estimated between 78 and 96 MPa [38], and six orders of magnitude smaller than 
mature cross-linked collagen I, estimated between 1 and 1.2 GPa [6, 35]. Given the fact that 
elastin and elastic fibers are robust structures that effectively last for the lifetime of the organ-
ism, studies have suggested that the elastic recoil generated in the elastic fibers cannot be a 
result of the stressing of the chemical bonds, since this would lead to the fiber deterioration 
[32]. Several studies have proposed that elastic recoil could be potentially attributed to the 
change in the number of conformation states of the cross-linked polypeptide chains during 
stretching and relaxation [6, 7, 13, 39]. Elaborating, under relaxed conditions the cross-linked 
polypeptide chains adopt a loose random coil conformation, which results in an increased 
number of different intramolecular conformational states in the chains. Under stretching, 
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the chains adopt a relatively aligned conformation, limiting their conformational freedom 
and, thus, decreasing their entropy. Under relaxation, the chains resume their random con-
formation, increasing the number of different conformational states and, thus, their entropy. 
This change in the entropy of the cross-linked chains has been suggested to provide the free 
energy for the elastic recoil [6, 23, 32]. Along these lines, it has been suggested that intra-
molecular folding of fibrillin molecules at their termini and Pro-rich regions, and at flexible 
sites between 8-Cys motifs, provides the extension/recoil mechanism of microfibrils [25, 27]. 
Similarly, cross-linked mature elastin has been suggested to derive its high elasticity from the 
cross-linking of Lys residues into desmosine, isodesmosine, and lysinonorleucine [7].
In contrast to collagens that can be encoded by large gene families, there is only one gene 
(ELN) that is responsible for synthesizing tropoelastin [40, 41]. Tropoelastin is mainly syn-
thesized in utero and early childhood, whereas by middle-age only a small amount of this 
molecule is produced [23, 42]. Owing to this, elastin is the longest lasting protein in the body, 
with a half-life of approximately 74 years [23, 43]. However, in the event of elastin damage 
due to acquired disease or aging, the low levels of tropoelastin produced mean that elastic 
fibers cannot be repaired sufficiently. Along these lines, loss of elasticity, due to degradative 
changes in elastic fibers, is a major contributing factor in connective tissue aging, and aortic 
aneurysm development [23, 25, 44, 45]. Elastic fiber degradation has also been reported to 
occur in atherosclerosis, with atherosclerotic vessels presenting increased stiffness, together 
with calcium and lipid accumulation in the elastic fibers [23, 46].
In the case of genetic disorders, mutations in the genes of the components of the elastic 
fibers have been associated with congenital disorders in elastic fiber-rich connective tissues. 
Specifically, Marfan syndrome and other overlapping disorders, such as MASS (mitral valve 
prolapse, aortic dilation, and skin/skeletal manifestations) syndrome, and autosomal TAAD 
(thoracic aortic aneurysms and dissections) [47], termed fibrillinopathies [48], have been asso-
ciated with fibrillin-1 mutations, leading to increased fragmentation of the elastic fibers that, 
in turn, lead to life-threatening cardiovascular disease and severe skeletal and ocular defects 
[13, 25, 38]. Progressive aortic valve root dilation, aortic dissection and rupture, and aortic or 
mitral valve regurgitation are the most serious conditions associated with Marfan syndrome, 
with a 90% mortality rate in these patients. Neonatal patients with Marfan syndrome die 
perinatally from congestive heart failure and valvular deficiency [38].
Increased fragmentation of the elastic fibers has also been reported in cutis laxa and Menkes 
disease, the latter of which is associated with tortuous blood vessels and abnormalities in 
other tissues [23]. Moreover, the pseudoxanthoma elasticum and Buschke-Ollendorff syn-
dromes have been associated with fragmentation, clumping and calcification of elastic fibers, 
leading to cardiovascular defects [23, 25]. Elastin mutations that cause elastin deficiency have 
been reported to cause reduced elastin content and disruption in the architecture of aorta and 
heart valves in Williams syndrome and supravalvular stenosis (SVAS) [23, 25, 29]. Elastin has 
been reported to induce actin stress fiber organization and inhibit SMC proliferation [24], 
indicating that apart from its structural role, elastin has a role in arterial morphogenesis [23]. 
Owing to this, reduction in the elastin content causes narrowing of the aorta and other arter-
ies, and SVAS [23, 25], due to the excessive proliferation of SMCs [13, 24].
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3. Glycosaminoglycans and proteoglycans
GAGs (also termed mucopolysaccharides) are the most abundant unbranched hetero-
polysaccharides in the body, composed of repeating disaccharide units [1]. Disaccharides 
are formed by two simple sugars (monosaccharides; basic units of carbohydrates), which are 
joined by dehydration synthesis. Polysaccharide chains are large, stiff and complex molecules 
that exist in tissues as highly viscous materials that interact with proteins and readily bind 
both water and cations. The GAGs derive their name from the fact that one of the two sugars 
in their repeating disaccharide unit is always an amino sugar, either N-acetylglucosamine 
(N-acetyl-D-glucosamine; GlcNAc) or N-acetylgalactosamine (N-acetyl-D-galactosamine; 
GalNAc) [1, 7, 13]. The other of the two sugars is usually either an uronic acid (glucuronic 
acid or iduronic acid) or D-galactose [1, 4, 13], whereas one or both of the sugars contain at 
least one anionic group (carboxyl or sulfate) [4], rendering GAGs highly negatively charged 
[13]. Owing to the relatively high stiffness and hydrophilicity of the polysaccharide chains, 
GAGs form extended conformations with a large volume to mass ratio, forming hydrated gels 
even at very low concentrations, and imparting high viscosity and, thus, low compressibility, 
to the ECM. The gel-forming character of the GAGs is due to their high negative charge that 
attracts cations, especially Na+, which causes large osmotic inflow of water into the ECM, 
creating a swelling pressure that enables the ECM to withstand compressive loads [1, 13]. 
The GAG gels can form with varying pore size and charge density, and it has been suggested 
that they act as selective sieves to regulate molecule and cell traffic according to their size and 
charge [13]. Although GAGs constitute less than 10% of the weight of the fibrous proteins 
in the ECM of connective tissues, their high volume to weight ratio and gel-forming ability 
enables them to fill most of the extracellular space, providing mechanical support to the tissue 
[7, 13], as well as lubrication between tissue (joints) and elastic and collagen fibers [2, 6].
Depending on the type of the repeating disaccharide unit, type of linkage between the sugars, 
and number and location of sulfate groups, GAGs are classified into four groups, including (i) 
hyaluronic acid, (ii) heparan sulfate and heparin, (iii) keratan sulfates (I and II), and (iv) chon-
droitin sulfates (chondroitin 4-sulfate and chondroitin 6-sulfate) and dermatan sulfate (Table 2) 
[1, 4, 13]. Hyaluronic acid is the simplest GAG and the only one that it does not contain any sul-
fate or attach covalently to proteins as a proteoglycan. However, it does form complexes with 
proteoglycans in the ECM, non-covalently [7]. All other GAGs contain sulfate groups, either as 
O-esters or as N-sulfate (in heparin and heparan sulfate) [1]. Heparin is a hyper-sulfated form of 
heparan sulfate that produced by mast cells and is an important anticoagulant that can activate 
the antithrombin III clotting inhibitor in plasma [1, 4]. It can also bind to the lipoprotein lipase, 
which is a membrane-associated enzyme present in capillary walls that hydrolyzes triglycer-
ides to fatty acids, causing its release into the circulation [1, 4]. Hyaluronic acid is abundant in 
embryonic tissues and has been suggested to play an important role in facilitating cell migra-
tion during morphogenesis and wound repair, whereas high concentrations of hyaluronic acid, 
as well as chondroitin sulfates, in tissues contribute to their compressibility. Keratan sulfates 
and dermatan sulfate lie between collagen fibrils and play a critical role in their alignment. 
Heparan sulfate is associated with cell membranes and has been suggested to act as a receptor 
mediating in cell growth and cell-cell and cell-ECM communication [1]. In adult tissues, GAGs 
have a slow turnover, with half-lives between days and weeks [1].
Structural Insufficiency Anomalies in Cardiac Valves12
With the exception of hyaluronic acid, all GAGs are found covalently linked to a polypep-
tide chain, or core protein, forming proteoglycans that are synthesized by most cell types [4]. 
Proteoglycans is a diverse group of highly glycosylated glycoproteins, which are distinguish-
able from other glycoproteins by the nature, quantity, and arrangement of their sugar side 
chains [13]. Proteoglycans feature at least one GAG side chain, whereas their carbohydrate 
content can reach up to 95% of their weight [1, 13]. On the other hand, the carbohydrate con-
tent of glycoproteins is between 1 and 60% of their weight, an is present in the form of numer-
ous relatively short, branched oligosaccharide chains [2, 13]. Proteoglycans have the potential 
of almost limitless heterogeneity [13], differentiating in the type of core protein, number and 
types of GAG chains, and number of disaccharide modifications by sulfate groups [1, 4, 13]. 
Some of the most common proteoglycans that have been characterized are listed in Table 2. 
Similarly to other proteins, the core proteins of proteoglycans are synthesized by ribosomes 
attached to the ER, and translocated into the lumen of the ER. Subsequently, the core protein 
is transported to the Golgi apparatus where it is glycosylated [1, 2]. During glycosylation, the 
GAGs are linked to their core proteins in one of three different modes. The first two modes 
involve the formation of O-glycosidic bonds between the hydroxyl side chains of serine (Ser) 
residues in the core protein and a xylose (Xyl) residue, which is unique to proteoglycans, 
or between Ser residues in the core protein and GalNAc residues in the GAG chain (kera-
tan sulfate II). In the first case, two Gal residues are subsequently added to the Xyl residue 
sequentially, forming a link trisaccharide (-Gal-Gal-Xyl-) that serves as a polysaccharide 
growth primer, followed by further linear growth of the GAG on the Gal terminal of the link 
trisaccharide (Figure 3). The third mode involves the formation of N-glycosylamine bonds, 
as found in N-linked glycoproteins, between the amide nitrogen of asparagine (Asn) residues 
in the core protein and the GlcNAc residues of the GAG chains [4, 13]. Subsequently, the 
polysaccharide chains are often modified in the Golgi apparatus by the covalent linkage of 
Table 2. Prevalent localization of different GAG types and their associated proteoglycans.
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small molecules, such as sulfate groups onto GalNAc and other moieties and the epimeriza-
tion of GlcUA to IdUA residues. Following glycosylation, the completed proteoglycan is then 
exported in secretory vesicles to the ECM [1, 4, 13].
In the extracellular space, proteoglycans bind various secreted signal molecules, such as growth 
factors, enhancing or inhibiting their signaling activity [13]. They also bind to other types of 
secreted proteins, including proteases and protease inhibitors, regulating their activities [1, 4]. 
Moreover, GAGs and proteoglycans can associate to each other to form big aggregates. Such a 
case is the aggrecan proteoglycans, which comprise chondroitin sulfate and keratan sulfate, and 
assemble with hyaluronic acid. GAGs and proteoglycans also associate with fibrous proteins, 
such as collagen and basal laminae, creating extremely complex structures. Such a proteoglycan 
is decorin, which comprises chondroitin sulfate and dermatan sulfate, and binds to collagen 
fibrils, aiding in collagen fiber formation. Decorin deficiency has been reported to lead to reduced 
tensile strength in tissues [13, 49–52]. Another proteoglycan of this type is perlecan, which is 
major proteoglycan of basal laminae, consisting of heparan sulfate and chondroitin sulfate chains 
linked to a large multi-domain core protein. Perlecan is incorporated in the basal laminae by 
binding to both laminin and collagen IV, connecting the two networks, and defining the structure 
and function of basal laminae. Owing to its multi-domain components, perlecan can also cross-
link cell surface molecules to ECM components [4]. In addition to proteoglycans that fully reside 
in the extracellular space, some proteoglycans form integral components of the cell membranes 
by having their core protein spanning or attached to the lipid bilayer of the cell membrane. Such 
proteoglycans are the syndecans, which comprise three chondroitin sulfate and heparan sulfate 
chains and are expressed by many cell types, including epithelial cells and fibroblasts [13, 53–55]. 
Syndecans bind to ECM collagens and other ECM proteins such as the fibronectins, anchoring 
cells to the ECM, while interacting with the intracellular actin cytoskeleton [4].
The importance of GAGs and proteoglycans is emphasized by the severe developmental 
defects that can occur when specific proteoglycans are inactivated by mutation. A number of 
congenital enzyme deficiencies have been linked to GAG metabolic disorders (mucopolysac-
charidoses) [13]. Among mucopolysaccharidoses, the Hurler [56–59] and Hunter [60–62] syn-
dromes are the most widely studied. Mucopolysaccharidoses are associated with mutations 
in the gene encoding lysosomal hydrolases, including endoglycosidases and exoglycosidases, 
Figure 3. Biosynthesis of proteoglycans, showing the case of the linking of chondroitin sulfate chains to their core 
protein. Ser: serine residue; Gal: galactose residue; GlcUA: glucuronic acid residue; Xyl: xylose residue. Modified from 
Alberts et al. (2014) [13] and Lodish et al. (2003) [4].
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which are enzymes involved in GAG degradation [56, 57, 62]. Absence or malfunctioning of 
lysosomal hydrolases lead to GAG accumulation in various tissues, including liver, spleen, 
bone, skin, and central nervous system [1, 60, 61]. Moreover, severe congenital deficiency in 
dermatan sulfate synthesis leads to a short stature, prematurely aged appearance, and general-
ized defects in the skin, joints, muscles, and bones of individuals [13]. GAGs and proteoglycans 
have also been associated with major diseases, such as cancer and atherosclerosis, and aging. 
The intima of arterial walls contains, among others, dermatan sulfate proteoglycans, which 
are synthesized by arterial SMCs and bind plasma low-density lipoproteins that are involved 
in atherosclerotic plaque development. Since atherosclerotic lesions feature increased prolif-
eration of SMCs, the dermatan sulfate content is increased in these sites, suggesting a potential 
role of this GAG in atherosclerotic plaque development [63]. Moreover, the amount of chon-
droitin sulfate diminishes with age, whereas the amounts of keratan sulfate and hyaluronic 
acid increase. These changes may contribute to conditions, such as osteoarthritis, and other 
degenerative diseases, as well as the characteristic changes in aged skin in the elderly [1, 2].
4. Structure and constituents of normal heart valves
Depending on the functional requirements for a particular tissue, the organization of fibers, cells 
and other ECM macromolecules in the tissue and, thus, the mechanical properties of the tissue 
vary. The simplest structure from the point of view of the collagen fibers consists of parallel fibers 
as in tendons and ligaments. The 2D and 3D networks of the skin are more complex, whereas the 
structures of aortic, pulmonary, mitral and tricuspid valves in the heart are the most complex 
ones. The structure of the heart valves is adapted to allow unidirectional and unobstructed pas-
sage of blood without regurgitation, trauma to blood elements, thromboembolism, and excessive 
stress concentrations in the valve leaflets and supporting tissue. The cellular and extracellular 
elements of normal valves accommodate repetitive changes in shape and dimension throughout 
the cardiac cycle. They provide effective stress transfer to the annulus and adjacent tissue, and 
mediate functional remodeling and repair of injury caused by the large repetitive deformations. 
The aortic and pulmonary valves comprise three similar-size leaflets, and are located between 
the left ventricle and aorta, and the right ventricle and pulmonary artery, respectively. Their 
leaflets resemble half-moons and, thus, they are referred to as semilunar (SL) valves. The mitral 
valve (MV) is located between the left ventricle and left atrium, and comprises two noticeably 
different leaflets that resemble a bishop’s miter when they are closed. The tricuspid valve is 
located between the right ventricle and right atrium, and comprises three leaflets. Owing to 
their location between the atria and the ventricles, the mitral and tricuspid valves are referred 
to as the atrioventricular (AV) valves. In addition to their leaflets, the AV valves also comprise 
fan-shaped tendinous chord (chordae tendinae) that link the AV valve leaflets to protrusions on 
the ventricular wall, the papillary muscles, and act similarly to the parachute chords, preventing 
the AV valve leaflets to prolapse into the atria when they are fully closed.
The aortic and pulmonary valve leaflets open against the aorta and pulmonary artery, respec-
tively, during ventricular systole, whereas the mitral and tricuspid valve leaflets open against 
the myocardial wall of the right and left ventricle, respectively, during ventricular dias-
tole. The semilunar valves close during ventricular diastole and the atrioventricular valves 
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during systole. All four valves close rapidly and completely under minimal reverse pressure, 
stretching to maintain full competence during diastole. During these opening and closing 
movements, the valve leaflets withstand cyclic strains as high as 50%, whereas despite the 
pressure difference across the closed valves, which imposes large load on their leaflets, leaflet 
prolapse is prevented by large coaptation of the leaflets, reaching up to 40% of their surfaces 
[18, 64–68]. Even though each of the four heart valves has its own individual unique anatomi-
cal, structural and constitutional features that are adapted to their specific localization and 
function, they share common structural, constitutional and functional features. Moreover, 
the aortic and mitral valves are the ones most prone to disease, since they reside in the high 
pressure environment of the left ventricle. Owing to these, the discussion in the following 
paragraphs is focused on the aortic and mitral valves, as representatives of the SL and AV 
valves, respectively. Moreover, the discussion will focus on valve leaflets, since these are the 
most structurally complex and constitutionally diverse components of the heart valves.
The heart valve leaflets are layered with a highly specialized ECM, which provides the basis 
for normal valve function. Two types of cells are present, including a layer of endothelial cells 
(ECs) that covers the luminal surface of the leaflets and a deep layer of interstitial cells (VICs) 
that consists of SMCs and fibroblasts, which replenish and remodel the valvular ECM [69]. The 
EC layer is continuous with the luminal surface of the atrium and ventricle, in the case of the 
AV valves, and ventricle and adjacent artery (pulmonary artery or aorta) in the case of the SL 
valves. The aortic valve leaflets comprise three distinct layers, including the fibrosa, spongiosa 
and ventricularis, each enriched in a different ECM component (Figure 4a–c, e). The MV leaflets 
present a slightly different architecture, with four layers instead of three, including a ventricu-
laris, a fibrosa, a spongiosa and an atrialis layer (Figure 4c, e). Within these layers, the structural 
elements are arranged in a methodical orientation, leading to leaflet properties that are highly 
anisotropic. Several structural features enable the semilunar and atrioventricular leaflets to be 
extremely soft and pliable when unloaded and inextensible when high transvalvular pressure is 
applied during the time the valves are fully closed [18, 65, 70, 71]. In the case of the aortic valve, 
the fibrosa layer faces the outflow (aorta side) of the valve, whereas in the case of the MV the 
fibrosa lies below a ventricularis layer, which faces the outflow (left ventricle side) of the valve. 
The fibrosa in both valve types is the primary structural layer and major load bearing layer that 
offers the mechanical integrity of the valve leaflets [72]. The predominant constituent of the 
fibrosa are large amounts of highly-aligned collagen I fibers (Figure 4c), which are organized 
into large bundles and are predominantly aligned along the circumferential direction of the 
leaflets. The collagen I fibers of the fibrosa are surrounded by glycosaminoglycans and proteo-
glycans, as well as a network of elastic fibers, which maintains the microstructure of the valve 
leaflet during unloading [73]. This directionality of the collagen fibers results in aortic and MV 
leaflet structures that are considerably stiffer along their circumferential direction than their 
radial [18, 67, 73]. Moreover, folds in the collagen layer of the fibrosa generate a macroscopically 
visible corrugations on the surface of the leaflets when they are un-stretched (Figure 4a).
The ventricularis layer of the aortic valve is equivalent to the atrialis of the MV in function 
and organization, with both facing the inflow of the valves. Although these layers are less 
organized than the fibrosa, they still contain significant amounts of collagen I (Figure 4c) and 
radially aligned elastic fibers (Figure 4d). However, because the collagen is not oriented in any 
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specific direction, they tend to be more flexible than the fibrosa. The elastic fibers of the aortic 
valve ventricularis and MV atrialis extend when the leaflets stretch to enlarge the coaptation 
area, but recoil to make the leaflet smaller in the open valve phase. The ventricularis of the MV 
Figure 4. (a) Trilaminar leaflet structure of semilunar valves, showing the fibrosa, spongiosa and ventricularis layers, 
together with their major constituents. Note the macroscopically visible corrugations of the fibrosa layer. (b) H & E 
histological staining of the aortic valve leaflet (radial direction). ECM proteins were stained pink/light purple; cells 
were stained deep/purple. (c) Immunohistochemical staining against collagen I of the mitral valve posterior leaflet 
(radial direction). Collagen I was stained brown. (d) Miller’s elastic histological staining of the aortic valve leaflet (radial 
direction). Elastic fibers were stained deep blue/black. (e) Alcian blue/PAS histological staining of the mitral valve 
anterior leaflet (radial direction), showing the ventricularis, fibrosa, spongiosa and atrialis layers; dark blue: cell nuclei; 
blue: acid mucosubstances (GAGs) and proteoglycans; magenta: Neutral polysaccharides.
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is similar in structure and constituents to the MV atrialis and aortic valve ventricularis, with 
loosely arranged collagen fibers and radially-aligned elastic fibers (Figure 5a). The spongiosa 
layer is located between the fibrosa and ventricularis of the aortic valve, and between the fibrosa 
and atrialis in the MV. This layer is primarily composed of water, GAGs and proteoglycans 
(Figure 4e), but also contains loosely arranged collagens and elastin, which connect the fibrosa 
and ventricularis (or atrialis) together. Shear stresses caused by the differential movements of 
the leaflet layers and the shock of the valve closure are dissipated in the ground substance of 
the spongiosa, whose hydrophilic GAGs and proteoglycans absorb water and swell to form a 
deformable gel [69]. The thickness of the leaflet layers varies from the attachment site (basal 
area) at the valvular annulus to the free edge of the leaflets [72, 73]. At the basal area, the fibrosa 
comprises the thickest layer, becoming thinner and gradually overtaken by the spongiosa 
towards the free edge of the leaflets (Figure 5b). The spongiosa is the main component of both 
the SL and AV valve leaflets at their free edge, providing a natural shock-absorption mechanism 
along the coaptation region of the leaflets that dissipates the shocks of valve closure [67, 73]. 
The thickest regions of the leaflets, especially close to their basal regions, also feature venules 
and arterioles, which facilitate supplementary oxygen and nutrient transport in regions where 
simple diffusion is not sufficient for cell nourishment (Figure 5a and b) [18, 66, 72, 74].
During the cardiac cycle, the SL and AV valve leaflets undergo significant changes in their mac-
roscale and microscale architectural configuration. When the valves are fully open, the gross 
corrugations of the fibrosa, which are caused by folds in the collagen fiber layer, produce a vis-
ible surface wrinkling (Figure 5c), which disappears when the leaflets are fully extended when 
the valve is fully closed and loaded under the peak transvalvular pressure (Figure 5d). During 
valve closing, the corrugations of the fibrosa expand along the radial direction, which is accom-
panied by radial stretching of the radially-aligned elastic fibers of the SL ventricularis (or MV 
atrialis) layer, permitting initial increase in dimension with minimal stress. Further stretching of 
the leaflets causes uncrimping of the collagen fibers along the circumferential direction. When 
the valve is fully closed, the collagen-layer folds are fully extended and the corrugations in the 
fibrosa are fully flattened along the radial direction, whereas collagen fibers are uncrimped 
along the circumferential direction. These changes produce stiffening of the leaflets, preventing 
their exaggerated sagging and ensuring optimal coaptation with the adjacent leaflets when the 
valve is fully closed [64, 69]. On the other hand, the stretching of the elastic fibers provides the 
energy that is necessary for the elastic recoil of the leaflets to their upstretched configuration 
when the valve is fully open. Moreover, the multilayered structure of the valve leaflets has been 
reported to contribute to the low flexural rigidity of the leaflets when the valves are fully open, 
possibly also due to interlayer slippage, that allows their passive interaction with the surround-
ing blood [75]. The multilayered leaflet structure also provides additional support during valve 
closure and coaptation, assisting the extended collagen fibers to generate a stiffened leaflet 
structure that prevents exaggerated sagging under the high transvalvular pressure [73].
In addition to collagen I, collagens III, IV, V and VI have also been identified in the heart 
valves [72, 76–78]. Even though these collagens are expressed in varying concentrations in 
the four valves, their localization and distribution has been shown to be similar in all valves. 
Apart from the fibrosa layer, were it is has a dominant presence, collagen I is expressed 
throughout the SL and AV valve leaflets (Figure 4c), whereas collagen III is most evident in 
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the less-dense regions of the leaflets, such as the spongiosa [76]. Collagen IV has been shown 
to be localized in the basal lamina of the leaflets and collagen V to be predominantly distrib-
uted around interstitial cells. Collagen VI has been shown to form distinct structures within 
the fibrosa, surrounding the dense collagen I fibers of this layer [76]. The total collagen con-
tent in normal valve leaflets is approximately 50–63% (dry tissue weight ratio) [68, 71, 79, 80], 
and the elastin content is approximately 10–11% (dry tissue weight ratio), depending on the 
valve type (Table 3) [78, 80–83]. Previous studies have reported the relative percentages of 
Figure 5. (a) Radial histological section of the basal region of the posterior MV leaflet stained with Miller’s elastic and 
sirius red (red: collagen; blue/black: elastin).  indicates elastic fibers; ► indicates blood vessels. Note the dominance 
of the fibrosa and ventricularis layers in the expense of the spongiosa layer in the basal region. (b) Radial histological 
section of the posterior MV leaflet stained with Masson’s Trichrome stain (blue/black: cell nuclei; red: cytoplasm; blue: 
collagen). ► indicates blood vessels. Note the increase in the thickness of the spongiosa layer and the decrease in the 
thickness of the fibrosa layer towards the free edge of the leaflet. Adopted with permission from Roberts et al. (2016) 
[18]. (c, d) leaflet configuration and architecture of semilunar valves during peak systole (c; fully open) and peak diastole 
(d; fully closed). Redrawn and modified from Schoen (1999) [64].
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collagen I, III, and V in normal human MV leaflets to be approximately 74, 24 and 2% of the 
total collagen content, respectively, whereas collagen IV and VI were below the detection 
limit of the technique used in those studies [72, 77]. A similar study by Lis et al. [78] reported 
a collagen I to collagen III ratio of 2.4 and 2.7 for human MV leaflets and chordae, respectively.
Three major GAGs have been identified in varying concentrations in heart valves, including 
chondroitin sulfate, dermatan sulfate and hyaluronic acid, together with decorin, biglycan 
and versican, which are chondroitin and dermatan sulfate proteoglycans [51, 84, 85]. The 
total content of sulfated GAGs (chondroitin and dermatan sulfate) in normal heart valves has 
been reported to range between 11 and 27% (dry tissue weight ratio), depending on valve 
type and site (Table 3) [68, 71, 78, 79]. Hyaluronic acid is the most abundant GAG in normal 
heart valves, accounting for up to half of the total leaflet GAG content, with chondroitin and 
dermatan sulfate accounting for about a quarter of the total GAG content of the leaflet each 
[86]. The relative percentages reported for normal human MV leaflets were 49, 25 and 23% of 
the total GAG content, for hyaluronic acid, chondroitin sulfate and dermatan sulfate, respec-
tively, with the remaining 3% attributed to hyper-sulfated chondroitin/dermatan sulfate. In 
the case of the normal MV chordae, the corresponding percentages have been reported to be 
24 (hyaluronic acid), 26 (chondroitin sulfate), 43 (dermatan sulfate) and 7% (hyper-sulfated 
chondroitin/dermatan sulfate) [84–86]. Moreover, differences in the absolute and relative 
GAG contents have been reported for different regions of the valves, subjected to different 
modes of loading during the cardiac cycle. Specifically, regions of the valves that are pre-
dominantly subjected to tensile loading, such as the leaflet belly and chordae (in the case of 
the AV valves), present a reduced overall GAG content compared to regions such as the free 
edge of the valve leaflets, which are predominantly subjected to compressive loading during 
coaptation with the other valve leaflets when the valve is fully closed. In addition, the regions 
that are predominantly subjected to tensile loading present significantly increased levels of 
chondroitin and dermatan sulfate compared to hyaluronic acid [85].
Content
Constituent Aortic Leaflet Pulmonary 
Leaflet
Mitral Leaflet Mitral Chordae
Hydroxyproline (μm/mg dry 
tissue)
71.6±26.1 (H)
[79]
70.7±6.2 (P)
[71]
88.2±3.9 (P)
[68]
88.6±7.1 (P)
[68]
Total collagens (μm/mg dry 
tissue)
511.2±186.3(H)
[79]
504.8±44.3 (P)
[71]
629.7±17.8 (P)
[68]
632.6±50.7 (P)
[68]
Sulfated GAGs (μm/mg dry 
tissue)
11.4±0.4 (H)
[79]
20.2±0.6 (P)
[71]
26.8±3.5 (P)
[68]
15.5±5.4(H)*
[78]
Elastin
(% of dry tissue weight)
11.2±1.0 (H)**
[81]
N.A. 10.0±17.8 (H) *
[78]
9.7±2.1 (H) *
[78]
The results indicate mean ± 95% confidence intervals, or mean ± standard deviation (*), or means ± standard error (**). 
H: Human; P: porcine; N.A.: not available. Numbers in brackets indicate source document.
Table 3. Hydroxyproline, collagen, sulfated GAG and elastin content of normal heart valves.
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5. Physiological behavior of heart valves under loading
The ultrastructural histoarchitecture of the valvular tissue and the interaction of its collagen 
fibers with its non-collagenous components form the basis of the mechanical properties of 
heart valves. Similarly to other biological tissues that are subjected to high deformation and 
loading, collagen and elastic fibers act synergistically in heart valves to provide valvular tis-
sue with strength and elasticity, respectively, which are required for their efficient function. 
The strength and stiffness of the collagen fibers prevent fracture of the valvular components 
when they are subjected to the peak transvalvular pressure during the time the valves are 
fully closed. The tensile strength of collagen is approximately 120 MPa, which is only one 
order of magnitude lower than high tensile steel (about 1110 MPa) and an elastic modulus 
of about 1.2 GPa, which confers substantial stiffness (Table 4) [35, 87]. However they stretch 
only minimally (about 13%) [35, 88]. On the other hand, elastic fibers are the most extensible 
biosolids known with very low modulus of approximately 0.3–1.1 MPa (Table 4) and capable 
of reaching failure strains in excess of 150%. However, elastic fibers demonstrate a low tensile 
strength of approximately 2 MPa, which limits their load-bearing capacity [35].
During the cardiac cycle, valvular tissue deforms to relative large strains, exhibiting non-linear 
stress-strain behavior. A typical stress-strain behavior for SL valve leaflet tissue within its 
physiological range is shown in Figure 6a. The graph describes the behavior of SL valve leaflets 
Material Young’s modulus / Elastic phase 
modulus (MPa)
Collagen phase modulus 
(MPa)
Source
Tropoelastin 0.003 - [37]
Microfibrils 78-96 [38]
Mature cross-linked elastin 0.3-1.1 - [6, 35]
Collagen 1 fibrils 95.5 [75]
Mature cross-linked collagen 1 - 1.0 - 1.2×103 [6, 35]
Aortic leaflet (C) 0.07 39.0 [65, 66]*
Aortic leaflet (R) 0.04 2.1
Pulmonary leaflet (C) 0.76 15.3 [71]*
Pulmonary leaflet (R) 0.34 1.2
Mitral leaflet (C) 0.02 10.2 [68]*
Mitral leaflet (R) 0.02 2.1
Mitral chordae 0.10 113.7
C: Circumferential direction, R: radial direction.
*Data obtained under uniaxial tensile testing.
Table 4. Indicative low-strain and high-strain modulus of valvular tissue and constituents.
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from peak systole, when the SL valves are fully open, to peak diastole, when the SL valves are 
fully closed and loaded by the maximum transvalvular pressure. The graph also shows the con-
tributions of the elastic and collagen fibers towards the overall behavior of the tissue and can be 
better comprehended in conjunction with Figure 5c and d. This type of stress-strain behavior 
has three distinct phases [65]. During the first phase (elastic phase), the leaflet offers little resis-
tance to elongation since force transmission and load bearing is provided mainly by the elastic 
fibers. During this phase the collagen layer in the fibrosa unfolds and the collagen fibrils change 
their angular distribution [75]. Owing to these, the collagen fibers have minimal contribution 
to force transmission, resulting in a stress-strain response for this phase that is characterized 
by a low slope (low modulus). In the elastic phase the leaflet tissue behaves almost as an elastic 
solid with the stress increasing linearly with the strain. Under further loading, the leaflet enters 
the transition phase, during which the collagen fibers uncrimp and gradually align and uncoil, 
increasing their contribution to the force transmission. In the collagen phase, all the collagen 
fibers are uncoiled (recruited) and the load is entirely borne by them. Further extension in the 
collagen fibers occurs by extrafibrillar (between molecules) and interfibrillar shear in the fibers, 
as well as molecular distortion [35]. Interfibrillar shear has been reported to be dependent on 
the amount of proteoglycans associated with the surface of the fibrils, which influences the 
extent of GAG association and electrostatic interactions between the fibrils and the surrounding 
ECM [35]. The slope of the stress-strain curve for the collagen phase is steep (high modulus) and 
almost constant, reflecting the material properties of the collagen fibers, which allow limited 
elongation to fracture [89]. Although the collagen phase of the leaflet continues well beyond the 
physiological range before failure, corresponding to the reserve strength of the collagen fibers, 
after peak systole the valve starts opening again and the stress is relieved whilst the leaflets 
recoil back to their original shape/size at peak systole. A similar non-linear stress-strain profile 
can be observed for the case of the leaflets and chordae of the AV valve during their closing 
phase from peak diastole to peak systole. Moreover, experimental studies have indicated that 
the stress-strain response of valve leaflets were independent of strain rate [75]. The Young’s 
modulus of different valvular tissue constituents, together with the elastic and collagen phase 
slopes of pulmonary and aortic valve leaflets, and MV leaflets and chordae, are listed in Table 4.
Similarly to other biological tissues, the stress-strain behavior of valvular tissue also demon-
strates viscoelastic behavior. Generally, viscoelasticity is manifested by a number of different 
features, including hysteresis, preconditioning, stress relaxation and creep. Viscoelasticity is 
a fundamental characteristic of biological materials, which exhibit both viscous and elastic 
behavior, depending on their constitution, temperature and the time over which the tissue is 
observed. Under cyclic loading (Figure 6b), valvular tissue exhibits a hysteresis loop (a phase 
lag) between loading and successive unloading. The area under the loading curve represents 
the energy stored during the extension of the tissue, whereas the area under the unloading 
curve represents the energy recovered during the recoil of the tissue back to its unloaded 
state. The hysteresis is the area between the loading and unloading curves of the stress-strain 
response and it is proportional to the mechanical energy dissipated. The hysteresis provides 
a measure of the energy storage efficiency of the tissue, with the larger the hysteresis the 
less efficient is the energy storage capacity of the tissue during loading and the less energy 
is returned to the system on unloading [90, 91]. Both collagen and elastic fibers do not show 
significant hysteresis, which makes them efficient in energy storage and able to provide the 
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necessary energy for rapid retraction of the valve leaflets during opening [35, 75, 91]. The 
energy storage capacity of the elastic fibers has been linked the high entropy of the elastin 
molecules. In the case of collagen, the intrafibrillar and interfibrillar shear, and molecular 
distortion that occur during the collagen fiber stretching has been suggested to contribute 
to the elastic energy storage [35]. Overall, valve leaflets have been reported to demonstrate a 
relatively low hysteresis of approximately 12% (in the case of the MV), which is independent 
of the strain rate [75].
Figure 6. (a) Structure-property relation of SL valve leaflets within physiological ranges of stress and strain. Redrawn 
and modified from Schoen (1999) [64]. (b) Successive loading and unloading of biological tissue, showing the hysteresis 
loop (hashed area). (c) Stress relaxation under constant strain. (d) Creep under constant stress.
Structure-Function Relationship of Heart Valves in Health and Disease
http://dx.doi.org/10.5772/intechopen.78280
23
Following altered loading conditions, valvular tissue reorganizes itself to compensate for the 
altered mechanical stress, demonstrating an initial period of adjustment in its stress-strain 
behavior under cyclic loading [75]. This adjustment is manifested by an increased hysteresis 
loop, which subsequently decreases, tending to a steady state after a number of loading/
unloading cycles. Once this steady state is reached, no further change occurs in the stress-
strain behavior, unless the loading routine is changed again. This period of adjustment after a 
large disturbance is called preconditioning and occurs due to internal changes in the structure 
of the tissue during cycling [6]. The viscoelastic feature of stress relaxation is manifested by 
the reduction of the stress generated in the tissue over time under constant strain (Figure 6c). 
Specifically, if the tissue is suddenly loaded to an initial stress σ
o
 and its length held constant, 
the stress relaxes asymptotically to a limiting value σ
1
 following an exponential decay. Creep 
is the counterpart of stress relaxation in the sense that the tissue is loaded to a strain ε
o
 and the 
stress is held constant. Under these conditions the specimen continuous to deform asymptoti-
cally to a limiting value ε
1
 (Figure 6d) [92]. Studies have reported that valve leaflets exhibit sig-
nificant stress relaxation, but negligible creep over time, suggesting that they behave more like 
anisotropic quasi-elastic materials rather than viscoelastic materials. This behavior suggests 
that valve leaflets exhibit a load-locking behavior under maintained loading conditions that 
enables them to withstand high loading without any time-dependent deformation effects [75].
The degrees of non-linear stress-strain behavior, hysteresis, preconditioning, stress relaxation 
and creep are different for different tissues, depending on the type and amount of their indi-
vidual constituents [6, 92]. Along these lines, the variability in the biomechanical properties 
between the different valves and valve components (Table 4) is predominantly due to the 
different fractions and organization of the major ECM constituents, including collagen fibers, 
elastic fibers, GAGs and proteoglycans, present in the different valves and valve components. 
These constitutional and organizational variations, which are dictated by the specific hemo-
dynamic and biomechanical environment that the valves reside in, bequeath high directional 
and regional histoarchitectural and biomechanical anisotropy to the valvular tissue, assisting 
the heart valves to perform their specific function in the four different sites of the heart.
6. Structural, constitutional and biomechanical alterations in 
pathological heart valves
Heart valve surgery for repairing or replacing dysfunctional represents the second most com-
mon major heart operation in the western world [93]. In the US alone, approximately 5 million 
patients are diagnosed annually with heart valve disease [75, 94, 95]. Any one of the heart 
valves can potentially demonstrated valve disease; however, the aortic and mitral valves are 
most prone to disease, predominantly due to the higher stress that are subjected to and gener-
ated by the high pressure environment of the left heart [75]. Various conditions in isolation or 
in combination can cause valve dysfunction, including inflammation, degenerative valve dis-
ease, calcification, rheumatic or infective endocarditis, myocardial infarction and congenital 
defects, such as bicuspid aortic valve (BAV), MV prolapse (MVP), isolated anomalous lobar 
pulmonary veins and silent patent ductus arteriosus [96, 97]. Valve disease is manifested by 
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disruptions and alterations in the ECM histoarchitecture and constitution, disruptions in the 
distribution and organization of the EC and VIC populations, and malformation of the heart 
valves, which can render them stenotic and/or regurgitant [74, 75]. Moreover, several ECM 
gene mutations have been linked to valve disease, including fibrillin 1 gene mutations, which 
have been associated with BAVs and MVP, and elastic fiber component gene mutations also 
associated with MVP (Williams and Marfan syndromes) [98–100]. MVP and pulmonary valve 
stenosis have also been linked to collagen III and tenascin X gene mutations [98], whereas 
Notch1 gene mutations have been associated with BAV development and early calcification 
[101, 102]. Several studies have suggested that the abnormal organization of the ECM induced 
by these mutations may lead to abnormal VIC signaling and subsequent dysregulation of 
ECM synthesis [98, 103–105].
BAVs in the most common form of congenital valve disease, affecting 1–2% of the general 
population and eventually leading to aortic valve stenosis or regurgitation, infective endo-
carditis, and aortic dilation and/or dissection later in life [80, 97, 98, 106, 107]. Stenotic BAVs 
explanted from pediatric patients have been reported to exhibit excessive ECM production 
and disorganization, and VIC disarray without calcification. [98]. Specifically, the valve leaf-
lets demonstrated loss of the typical trilaminar structure of the normal aortic valve leaflets, 
with disorganized, fragmented and abnormally oriented collagen and elastic fibers, increased 
proteoglycan presence throughout the leaflets, leaflet thickening, and large areas relatively 
void of cells. Moreover, elastin content was decreased, whereas collagen and proteoglycan 
content were substantially increased [75, 98]. The abnormalities in BAV histoarchitecture, 
constitution and anatomy, have been show to affect leaflet kinematics and stress distribu-
tion in computational studies, suggesting that early occurrence of regurgitation or stenosis 
might strictly depend on those abnormalities [107]. Alterations in the mechanical loading of 
the heart valves, due to abnormalities in histoarchitecture, constitution and anatomy, induce 
tissue remodeling though abnormal VIC mechanotransduction, which can lead to further 
valvular disease and dysfunction. Several studies have characterized VIC response against 
alterations in the biomechanical environment, and demonstrated a clear link between abnor-
mal VIC stimulation, valvular tissue deformations and disease development and progression, 
highlighting the fundamental role of the mechanical environment on the mechanobiology 
of VICs [108–111]. As a result, BAVs are highly susceptible to calcification in later life, due 
to an induced osteoblastic VIC phenotype and subsequent matrix mineralization [80, 112]. 
Calcification causes valvular tissue to become thicker and stiffer (representative of a higher 
modulus), which eventually leads to valve stenosis and inevitable valve replacement [75].
Calcified aortic valve disease (CAVD) is not restricted to BAVs alone. CAVD is a slow, progres-
sive, multifactorial disorder that is frequently driven by aging and the obesity-associated meta-
bolic syndrome, and affects 25–30% of the population aged over 65 years old [75, 84, 100, 105, 
113, 114]. Initially, the disease in manifested by mild leaflet thickening of the leaflets alongside 
with increase in the proteoglycan and hyaluronic acid content, which progressively become more 
severe and lead to impaired leaflet motion, valvular tissue adaptation and stenosis, [75, 84]. In 
spite of the leaflet thickening, studies have indicated that there is little change in the mechanical 
properties of the valve at the early stages of the disease [75]. Although this makes the condition 
asymptomatic at its initial phases, 10% of the patients develop severe symptoms within 10 years 
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of the initial diagnosis, and require immediate AV replacement [115]. Accumulating evidence 
suggests that apart from the upregulation of certain cellular pathways that can activate VIC trans-
differentiation into osteogenic phenotype and promote osteogenic ECM remodeling, several 
non-cellular mechanisms, such as epitaxial calcification, can also induce calcium deposition in 
heart valves [116]. Calcific deposits in CAVD typically occur in regions of high stress concentra-
tion [117], highlighting the importance of mechanical factors in valve calcification, and initiate on 
the outflow surface of the leaflets [80, 106, 118]. It has been hypothesized that valvular ECs may 
regulate VIC function, and that the initiation of calcific deposits on the outflow, rather than the 
inflow, surface of the leaflets is due to differences in the hemodynamic microenvironment on the 
two sides of the leaflet. Elaborating, the different hemodynamic environments generate differ-
ent mechanical forces that induce different phenotypic modulations on the ECs on the oppos-
ing sides. This, in turn, causes variations in the regulation of VIC function [80, 119]. Moreover, 
accumulating evidence suggests that CAVD shares common features with atherosclerosis, 
particularly the early accumulation of low-density lipoproteins (LDL), possibly by proteoglycan 
retention, and the attraction of inflammatory cells by hyaluronic acid, in the early stages of both 
pathologies [84]. These commonalities have led to the suggestion that there might be an regula-
tory mechanism of CAVD, similar to that in arterial atherosclerosis [84, 106, 120]. It has been sug-
gested that a potential mediator of the hemodynamics-induced differential EC modulation might 
be Kruppel-like factor 2 (KLF2) [80]. KLF2 is a shear-stress-regulated transcription factor that is 
selectively induced in ECs localized in arterial regions that are protected from atherosclerosis 
[121]. Along these lines, ECs exposed to the same shear stress as the inflow surface of the aortic 
valve leaflets, demonstrated upregulation of KLF2 relatively to ECs exposed to shear stress levels 
equivalent to the outflow surface the aortic leaflets [80]. Moreover, it has also been suggested that 
the initiation of calcific deposits on the outflow surface of the leaflets might be due to the presence 
of nucleation sites, which provide the starting point for calcium nodule formation [75].
MVP is another common form of congenital valve disease that affects more than 2% of the gen-
eral population, and it is the most common indication for surgical MV repair or replacement. 
MVP refers to the displacement of one (unileaflet MVP) or both (bileaflet MVP) MV leaflets into 
the left atrium during systole [80]. MVP is not apparent at birth and it usually remains asymp-
tomatic till late adulthood [75, 80]. The condition is characterized by gross changes in the MV 
components, including thickening, enlargement and hooding of the leaflets, annular dilation, 
and elongated and/or ruptured chordae [86, 122]. The underlying pathology of MVP is myxo-
matous degeneration, which is defined by the abnormal accumulation of mucopolysaccharides. 
The pathology engulfs a number of processes, including diminishing of the fibrosa and thick-
ening of the spongiosa layer of the leaflets, increased cellularity in the spongiosa, deposition 
of randomly orientated collagens, accumulation of GAG- and proteoglycan-rich myxomatous 
material in the leaflets and chordae, fragmentation of collagen and elastic fibers, and production 
of abundant matrix metalloproteases [80, 86, 123, 124]. These changes in the histoarchitecture 
and constitution lead to the biomechanical weakening of the MV components, which ultimately 
leads to mitral regurgitation, thromboembolism, heart failure and atrial fibrillation [75, 80]. 
Myxomatous MVs have been reported to demonstrate a lower strength, increased extensibility 
and decreased modulus compared to normal MVs in both the leaflets and chordae [86, 125, 
126]. Myxomatous degeneration has also been reported to affect the biomechanical integrity 
of the chordae more that it does in the case of the leaflets [125, 126]. This finding is in accord 
with clinical reports that have indicated that most cases of myxomatous mitral regurgitation 
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involve chordal elongation and/or rupture rather than isolated leaflet prolapse due to annular 
dilation [86, 122]. In terms of constitution, human myxomatous MV leaflets and chordae have 
been reported to contain 3–9% more water and 2.4–7% more collagen compared to the normal 
tissues. In addition, the myxomatous leaflets and chordae contained 30–150% more GAGs com-
pared to the normal tissues, with chordae from unileaflet prolapsing valves demonstrating 62% 
more GAGs than chordae from bileaflet ones [86]. The alteration in the histoarchitecture and 
biochemical constitution is an attribute of the altered biosynthetic response of the VICs [80]. 
This leads to the pathological remodeling of the myxomatous valves, which coupled with their 
normal wear induced during the cyclic loading, leads to the deterioration of their mechani-
cal integrity. As discussed above, abnormalities in histoarchitecture and constitution cause 
alterations in the mechanical loading generated in the heart valves and, thus, abnormal VIC 
mechanotransduction. Indeed, VICs have been shown to respond to mechanical strain in vitro 
and modulate their biosynthetic and ECM-degradation activity. Under cyclic straining, VICs, 
isolated from porcine MV leaflets and chordae, produced upregulation of GAGs, with chordal 
VICs responding more rapidly to the cyclic strain than leaflet VICs [127, 128]. Moreover, stud-
ies with human MV explants have reported that during MVP development, healthy quiescent 
VICs undergo a phenotypic activation though the upregulation of the BMP4-mediated pathway 
[75, 129, 130]. BMP4 is an osteogenic morphogen that, together with BMP2, have been shown to 
be present in ossified valves [131]. BMP4 is also a potent inducer of collagen and proteoglycan 
synthesis, and matrix mineralization [75].
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